Medtronic Operating Expenses 2010-2025 | MDT
- Medtronic operating expenses for the quarter ending April 30, 2025 were $7.490B, a 0.61% decline year-over-year.
- Medtronic operating expenses for the twelve months ending April 30, 2025 were $27.581B, a 1.33% increase year-over-year.
- Medtronic annual operating expenses for 2025 were $27.581B, a 1.33% increase from 2024.
- Medtronic annual operating expenses for 2024 were $27.219B, a 5.74% increase from 2023.
- Medtronic annual operating expenses for 2023 were $25.742B, a 0.74% decline from 2022.
Medtronic Annual Operating Expenses (Millions of US $) |
|
---|---|
2025 | $27,581 |
2024 | $27,219 |
2023 | $25,742 |
2022 | $25,933 |
2021 | $25,633 |
2020 | $24,122 |
2019 | $24,289 |
2018 | $23,313 |
2017 | $24,327 |
2016 | $23,472 |
2015 | $16,495 |
2014 | $13,192 |
2013 | $11,835 |
2012 | $11,436 |
2011 | $11,211 |
2010 | $10,678 |
2009 | $10,766 |
Medtronic Quarterly Operating Expenses (Millions of US $) |
|
---|---|
2025-04-30 | $7,490 |
2025-01-31 | $6,647 |
2024-10-31 | $6,809 |
2024-07-31 | $6,635 |
2024-04-30 | $7,536 |
2024-01-31 | $6,606 |
2023-10-31 | $6,644 |
2023-07-31 | $6,433 |
2023-04-30 | $6,977 |
2023-01-31 | $6,336 |
2022-10-31 | $6,182 |
2022-07-31 | $6,247 |
2022-04-30 | $6,417 |
2022-01-31 | $6,104 |
2021-10-31 | $6,284 |
2021-07-31 | $7,128 |
2021-04-30 | $6,584 |
2021-01-31 | $6,498 |
2020-10-31 | $6,717 |
2020-07-31 | $5,834 |
2020-04-30 | $5,681 |
2020-01-31 | $6,078 |
2019-10-31 | $6,355 |
2019-07-31 | $6,008 |
2019-04-30 | $6,200 |
2019-01-31 | $6,004 |
2018-10-31 | $5,937 |
2018-07-31 | $6,148 |
2018-04-30 | $6,216 |
2018-01-31 | $5,933 |
2017-10-31 | $5,156 |
2017-07-31 | $6,008 |
2017-04-30 | $6,232 |
2017-01-31 | $6,136 |
2016-10-31 | $5,960 |
2016-07-31 | $5,999 |
2016-04-30 | $5,992 |
2016-01-31 | $5,579 |
2015-10-31 | $5,758 |
2015-07-31 | $6,143 |
2015-04-30 | $7,145 |
2015-01-31 | $3,043 |
2014-10-31 | $3,173 |
2014-07-31 | $3,134 |
2014-04-30 | $4,260 |
2014-01-31 | $3,138 |
2013-10-31 | $2,988 |
2013-07-31 | $2,806 |
2013-04-30 | $3,269 |
2013-01-31 | $2,809 |
2012-10-31 | $2,909 |
2012-07-31 | $2,848 |
2012-04-30 | $3,082 |
2012-01-31 | $2,765 |
2011-10-31 | $2,802 |
2011-07-31 | $2,787 |
2011-04-30 | $2,993 |
2011-01-31 | $2,710 |
2010-10-31 | $2,814 |
2010-07-31 | $2,694 |
2010-04-30 | $2,714 |
2010-01-31 | $2,584 |
2009-10-31 | $2,614 |
2009-07-31 | $2,766 |
2009-04-30 | $3,169 |
2009-01-31 | $2,514 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $119.200B | $33.537B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $220.159B | 25.82 |
Boston Scientific (BSX) | United States | $157.028B | 37.51 |
Stryker (SYK) | United States | $154.023B | 32.21 |
EssilorLuxottica (ESLOY) | France | $136.572B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $50.282B | 0.00 |
Haleon (HLN) | United Kingdom | $44.384B | 25.33 |
ResMed (RMD) | United States | $40.346B | 30.30 |
GE HealthCare Technologies (GEHC) | United States | $35.536B | 16.87 |
Agilent Technologies (A) | United States | $34.139B | 22.26 |
Terumo (TRUMY) | Japan | $25.843B | 33.57 |
Koninklijke Philips (PHG) | Netherlands | $25.190B | 17.68 |
Insulet (PODD) | United States | $20.424B | 80.17 |
Zimmer Biomet Holdings (ZBH) | United States | $19.300B | 12.40 |
Baxter (BAX) | United States | $14.995B | 11.19 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.871B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
Demant (WILYY) | Denmark | $8.633B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.189B | 25.02 |
Lantheus Holdings (LNTH) | United States | $5.046B | 12.73 |
Perrigo (PRGO) | Ireland | $3.908B | 9.91 |
Prestige Consumer Healthcare (PBH) | United States | $3.799B | 16.97 |
Haemonetics (HAE) | United States | $3.613B | 16.45 |
Envista Holdings (NVST) | United States | $3.525B | 29.30 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
ICU Medical (ICUI) | United States | $3.197B | 23.58 |
LeMaitre Vascular (LMAT) | United States | $1.862B | 41.63 |
QuidelOrtho (QDEL) | United States | $1.852B | 12.74 |
AtriCure (ATRC) | United States | $1.559B | 0.00 |
Acuren (TIC) | United States | $1.441B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.332B | 29.95 |
AdaptHealth (AHCO) | United States | $1.274B | 12.93 |
Phibro Animal Health (PAHC) | United States | $1.183B | 15.12 |
Neogen (NEOG) | United States | $1.133B | 14.50 |
BioLife Solutions (BLFS) | United States | $1.080B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.964B | 0.00 |
InMode (INMD) | Israel | $0.930B | 9.38 |
Kestra Medical Technologies (KMTS) | United States | $0.850B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.693B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
Valneva SE (VALN) | France | $0.654B | 0.00 |
Evolus (EOLS) | United States | $0.614B | 0.00 |
Owens & Minor (OMI) | United States | $0.609B | 5.05 |
CeriBell (CBLL) | United States | $0.547B | 0.00 |
ZimVie (ZIMV) | United States | $0.521B | 23.70 |
Surmodics (SRDX) | United States | $0.515B | 0.00 |
SNDL (SNDL) | Canada | $0.398B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
Capricor Therapeutics (CAPR) | United States | $0.322B | 0.00 |
Quanterix (QTRX) | United States | $0.292B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.272B | 80.67 |
Cerus (CERS) | United States | $0.266B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.242B | 20.40 |
Biote (BTMD) | United States | $0.236B | 6.65 |
Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.230B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.227B | 0.00 |
Omeros (OMER) | United States | $0.224B | 0.00 |
Brainsway (BWAY) | Israel | $0.222B | 58.65 |
Organigram Global (OGI) | Canada | $0.205B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.190B | 15.65 |
High Tide (HITI) | Canada | $0.188B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
Exagen (XGN) | United States | $0.155B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.135B | 0.00 |
FitLife Brands (FTLF) | United States | $0.121B | 0.00 |
MacroGenics (MGNX) | United States | $0.108B | 0.00 |
Jin Medical (ZJYL) | China | $0.102B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
Fonar (FONR) | United States | $0.100B | 12.86 |
Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
Apyx Medical (APYX) | United States | $0.096B | 0.00 |
Safety Shot (SHOT) | United States | $0.090B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.082B | 0.00 |
Zynex (ZYXI) | United States | $0.078B | 0.00 |
InterCure (INCR) | Israel | $0.071B | 0.00 |
Agape ATP (ATPC) | $0.066B | 0.00 | |
ImmuCell (ICCC) | United States | $0.060B | 0.00 |
Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
Modular Medical (MODD) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.29 |
Nephros (NEPH) | United States | $0.038B | 51.00 |
Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.014B | 0.00 |
Senestech (SNES) | United States | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
Sharps Technology (STSS) | United States | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |